KRAS and cancer: These targets include K-Ras4b (hereafter simply referredto as K-Ras), which is one of the most widely mutated cancer oncogenes.9−11 The hypervariable region of K-Ras exhibits a patch of lysine residuesthat aid in transiently associating K-Ras with the PM upon post-translationalfarnesylation.